 CRANBURY, N.J., Sept. 02, 2021 GLOBE NEWSWIRE -- PMV Pharmaceuticals, Inc. Nasdaq: PMVP, a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53 mutants, today announced that David H. Mack, Ph.D., President Chief Executive Officer, will present at the Morgan Stanley 19th Annual Global Healthcare Conference taking place September 9-10 and 13-15, 2021. The company will also participate in one-on-one investor meetings at the conference. 